Anonymous
Guest
Anonymous
Guest
OK you are right all the companies I named are pharma companies,But the question still remains name me an institution or another research oriented company that can afford to swing an aquisition of this size in this economic enviornment,I agree that C.V will eventually be sold off but I think it will take longer than a year.Despite what Kindler has said Pfizers aquisition of Wyeth was nothing but an asset grab to keep Pfizer afloat for another couple of years.Pfizer had an easier time unloading the realestate from prior aquisitions because of a better economic climate in todays climate G.V is the easier sell it is basically office space.With all the lab space in C.V it narrows the list of prospective buyers significantly.Right now and not for the forseeable future there is noone out there that can afford this type of aquisition.So if you think there is a buyer out there name them.
It is easier to change lab space into office space than the other way around.